NCT04094610 2025-11-19A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 AlterationsTurning Point Therapeutics, Inc.Phase 1/2 Recruiting75 enrolled
NCT06597916 2024-11-27RSV Vaccination in Immunocompromised Patients.Medical University of ViennaPhase 2 Recruiting200 enrolled